Skip to main content
logo
Cyfuse Biomedical K.K. (TYO:4892)
Japan flag Japan · Delayed Price · Currency is JPY
570.00
0.00 (0.00%)
Aug 27, 2026, 3:30 PM JST

Cyfuse Biomedical K.K. Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,6795,6713,6775,9579,559-
Market Cap Growth
6.52%54.23%-38.27%-37.68%--
Enterprise Value
3,5203,1741,2912,9358,036-
Last Close Price
570.00590.00452.00762.001301.00-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.6224.6668.0997.6525.56-
PB Ratio
2.172.061.451.862.54-
P/TBV Ratio
2.172.061.451.862.54-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.5413.8023.9148.1121.49-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.470.480.340.280.240.30
Net Debt / Equity Ratio
-0.82-0.88-0.86-0.92-0.94-0.97
Net Debt / EBITDA Ratio
2.913.052.564.519.75-
Net Debt / FCF Ratio
3.104.162.875.105.59-
Asset Turnover
0.090.060.010.010.100.29
Inventory Turnover
2.061.640.750.542.633.34
Quick Ratio
3.704.364.815.896.616.40
Current Ratio
3.884.545.005.996.696.63
Return on Equity (ROE)
-32.12%-28.80%-30.36%-16.90%-16.69%8.23%
Return on Assets (ROA)
-13.54%-13.31%-14.49%-9.65%-7.12%1.83%
Return on Invested Capital (ROIC)
-169.96%-242.75%-306.85%-289.81%-290.10%241.43%
Return on Capital Employed (ROCE)
-25.80%-24.40%-31.20%-19.60%-10.30%3.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-14.00%-13.46%-23.71%-9.89%-4.95%-
FCF Yield
-12.25%-10.24%-20.89%-9.75%-6.60%-
Buyback Yield / Dilution
-18.27%-9.33%-3.05%-192.85%-432.99%-